{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:14:31Z","timestamp":1773933271232,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP 23bm1123021"],"award-info":[{"award-number":["JP 23bm1123021"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP 23bm1223018"],"award-info":[{"award-number":["JP 23bm1223018"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP 20am0401017"],"award-info":[{"award-number":["JP 20am0401017"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03515"],"award-info":[{"award-number":["19H03515"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02921"],"award-info":[{"award-number":["22H02921"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ymthe.2025.10.055","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:25:14Z","timestamp":1761841514000},"page":"1104-1118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell-cell fusion and immunostimulatory cytokines significantly impact oncolytic vaccinia virus immunotherapeutic potential"],"prefix":"10.1016","volume":"34","author":[{"given":"Motomu","family":"Nakatake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Itadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0196-0754","authenticated-orcid":false,"given":"Takafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.055_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40425-016-0116-2","article-title":"Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study","volume":"4","author":"Kaufman","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.055_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-016-0158-5","article-title":"Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy","volume":"4","author":"Rehman","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.055_bib3","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41467-022-31262-y","article-title":"A phase I\/II study of triple-mutated oncolytic herpes virus G47\u0394 in patients with progressive glioblastoma","volume":"13","author":"Todo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.055_bib4","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u0394 for residual or recurrent glioblastoma: A phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.10.055_bib5","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.10.055_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/cells10050985","article-title":"Anti-tumor effects of MAPK-dependent tumor-selective oncolytic vaccinia virus armed with CD\/UPRT against pancreatic ductal adenocarcinoma in mice","volume":"10","author":"Kurosaki","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.10.055_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/cas.16032","article-title":"Histone deacetylase inhibitor boosts anticancer potential of fusogenic oncolytic vaccinia virus by enhancing cell-cell fusion","volume":"115","author":"Nakatake","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ymthe.2025.10.055_bib8","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2020.12.024","article-title":"Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment","volume":"29","author":"Nakatake","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.055_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0264-410X(94)90215-1","article-title":"Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines","volume":"12","author":"Sugimoto","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2025.10.055_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax7992","article-title":"Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade","volume":"12","author":"Nakao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.10.055_bib11","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1007\/s00262-021-02947-y","article-title":"IL-7 coupled with IL-12 increases intratumoral T cell clonality, leading to complete regression of non-immunogenic tumors","volume":"70","author":"Tasaki","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.10.055_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00262-014-1523-1","article-title":"Interleukin 12: Still a promising candidate for tumor immunotherapy?","volume":"63","author":"Lasek","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.10.055_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.4049\/jimmunol.1800348","article-title":"Formation of the intrathymic dendritic cell pool requires CCL21-mediated recruitment of CCR7+ progenitors to the thymus","volume":"201","author":"Cosway","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.055_bib14","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.4049\/jimmunol.170.9.4638","article-title":"Naive T cell recruitment to nonlymphoid tissues: A role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis","volume":"170","author":"Weninger","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.055_bib15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3390\/v15081645","article-title":"Oncolytic virus engineering and utilizations: Cancer immunotherapy perspective","volume":"15","author":"Muthukutty","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.10.055_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-022-00951-x","article-title":"Engineering strategies to enhance oncolytic viruses in cancer immunotherapy","volume":"7","author":"Tian","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.10.055_bib17","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.055_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/019262339902700112","article-title":"The toxicology of interleukin-12: A review","volume":"27","author":"Car","year":"1999","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2025.10.055_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.952231","article-title":"IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.055_bib20","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.055_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101435","article-title":"Memory CD8+ T cell responses to cancer","volume":"49","author":"Han","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.055_bib22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.10.055_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41591-019-0734-6","article-title":"Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma","volume":"26","author":"Fairfax","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.10.055_bib24","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.10.055_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cas.15195","article-title":"Circulating naive and effector memory T cells correlate with prognosis in head and neck squamous cell carcinoma","volume":"113","author":"Takahashi","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ymthe.2025.10.055_bib26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2009-02-203935","article-title":"Type 17 CD8+ T cells display enhanced antitumor immunity","volume":"114","author":"Hinrichs","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.10.055_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2016.05.001","article-title":"IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease","volume":"178","author":"Srenathan","year":"2016","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ymthe.2025.10.055_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13046-022-02566-0","article-title":"T-cell repertoire diversity: Friend or foe for protective antitumor response?","volume":"41","author":"Porciello","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.055_bib29","article-title":"Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection","volume":"14","author":"D'Alise","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.10.055_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2020.08.053","article-title":"A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer","volume":"183","author":"Ott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.10.055_bib31","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1158\/0008-5472.CAN-10-1326","article-title":"Dacarbazine treatment before peptide vaccination enlarges T-cell repertoire diversity of melan-a-specific, tumor-reactive CTL in melanoma patients","volume":"70","author":"Palermo","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2025.10.055_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/2326-6066.CIR-22-0517","article-title":"Clonal spreading of tumor-infiltrating T cells underlies the robust antitumor immune responses","volume":"11","author":"Aoki","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.10.055_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1158\/2326-6066.CIR-19-0398","article-title":"TCR repertoire diversity of peripheral PD-1+CD8+ T cells predicts clinical outcomes after immunotherapy in patients with non-small cell lung cancer","volume":"8","author":"Han","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.10.055_bib34","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1038\/s41467-021-24343-x","article-title":"The T cell receptor repertoire of tumor-infiltrating T cells is predictive and prognostic for cancer survival","volume":"12","author":"Valpione","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.055_bib35","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-024-00760-x","article-title":"An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy","volume":"5","author":"Chen","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2025.10.055_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300723","article-title":"Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies","volume":"19","author":"Griffin","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.055_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584423","article-title":"Tumor infiltrating effector memory antigen-specific CD8+ T cells predict response to immune checkpoint therapy","volume":"11","author":"Principe","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.055_bib38","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.10.055_bib39","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2025.10.055_bib40","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1038\/s41467-021-23324-4","article-title":"Interpretation of T cell states from single-cell transcriptomics data using reference atlases","volume":"12","author":"Andreatta","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.10.055_bib41","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.ymthe.2025.10.055_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","article-title":"Robust decomposition of cell type mixtures in spatial transcriptomics","volume":"40","author":"Cable","year":"2022","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500930X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500930X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:50:52Z","timestamp":1773924652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162500930X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S152500162500930X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.055","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-cell fusion and immunostimulatory cytokines significantly impact oncolytic vaccinia virus immunotherapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}